Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Falk, Anna"'
Autor:
Lundin A; Translational Genomics, BioPharmaceuticals R&D, Discovery Sciences, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal, 431 83, Sweden., Ricchiuto P; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Darwin Building, 310 Milton Rd, Cambridge, CB4 0WG, UK., Clausen M; Translational Genomics, BioPharmaceuticals R&D, Discovery Sciences, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal, 431 83, Sweden., Hicks R; Translational Genomics, BioPharmaceuticals R&D, Discovery Sciences, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal, 431 83, Sweden., Falk A; Department of Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden., Herland A; Department of Neuroscience, Karolinska Institutet, Stockholm, 17177, Sweden.; Division of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, 10044, Sweden.; AIMES, Center for the Advancement of Integrated Medical and Engineering Sciences, Karolinska Institutet, Stockholm, 17177, Sweden.
Publikováno v:
Advanced biosystems [Adv Biosyst] 2020 May; Vol. 4 (5), pp. e1900226. Date of Electronic Publication: 2020 Apr 06.
Autor:
Sobol M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden., Klar J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden., Laan L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden., Shahsavani M; Department of Neuroscience, Karolinska Institutet Solna, SE-171 65, Stockholm, Sweden., Schuster J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden., Annerén G; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden., Konzer A; Department of Chemistry - BMC, Analytical Chemistry, Uppsala University, Box 599, SE-751 24, Uppsala, Sweden., Mi J; Department of Chemistry - BMC, Analytical Chemistry, Uppsala University, Box 599, SE-751 24, Uppsala, Sweden., Bergquist J; Department of Chemistry - BMC, Analytical Chemistry, Uppsala University, Box 599, SE-751 24, Uppsala, Sweden., Nordlund J; Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Box 1432, SE-751 44, Uppsala, Sweden., Hoeber J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden., Huss M; Department of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm University, Box 1031, SE-171 21, Solna, Sweden., Falk A; Department of Neuroscience, Karolinska Institutet Solna, SE-171 65, Stockholm, Sweden., Dahl N; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, SE-751 08, Uppsala, Sweden. niklas.dahl@igp.uu.se.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2019 Oct; Vol. 56 (10), pp. 7113-7127. Date of Electronic Publication: 2019 Apr 13.
Autor:
Delsing L; Department of Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, Sweden.; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden., Dönnes P; SciCross AB, Skövde, Sweden., Sánchez J; Biostatistics, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden., Clausen M; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden., Voulgaris D; Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden., Falk A; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Herland A; Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden.; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden., Brolén G; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden., Zetterberg H; Department of Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK., Hicks R; Discovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden., Synnergren J; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, Sweden.
Publikováno v:
Stem cells (Dayton, Ohio) [Stem Cells] 2018 Dec; Vol. 36 (12), pp. 1816-1827. Date of Electronic Publication: 2018 Nov 05.
Autor:
Yu NY; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden., Bieder A; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden., Raman A; Department of Medicine (MedH), Karolinska Institutet, Huddinge, SE-141 86, Sweden., Mileti E; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden., Katayama S; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden., Einarsdottir E; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden.; Folkhälsan Institute of Genetics, and Molecular Neurology Research Program, University of Helsinki, Helsinki, 00014, Finland., Fredholm BB; Department of Physiology and Pharmacology, Karolinska Institutet, Solna, SE-171 77, Sweden., Falk A; Department of Neuroscience, Karolinska Institutet, Solna, SE-171 77, Sweden., Tapia-Páez I; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden.; Department of Medicine/Center for Molecular Medicine, Karolinska University Hospital, Solna, SE-171 76, Sweden., Daub CO; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden.; Division of Genomic Technologies, RIKEN Center for Life Science Technologies, Tsurumi, Yokohama, Kanagawa, #230-0045, Japan., Kere J; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83, Sweden. juha.kere@ki.se.; Folkhälsan Institute of Genetics, and Molecular Neurology Research Program, University of Helsinki, Helsinki, 00014, Finland. juha.kere@ki.se.; Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, United Kingdom. juha.kere@ki.se.
Publikováno v:
Scientific reports [Sci Rep] 2017 Sep 13; Vol. 7 (1), pp. 11458. Date of Electronic Publication: 2017 Sep 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Delsing, Louise, Dönnes, Pierre, Sánchez, José, Clausen, Maryam, Voulgaris, Dmitrios, Falk, Anna, Herland, Anna, Brolén, Gabriella, Zetterberg, Henrik, Hicks, Ryan, Synnergren, Jane
Cell-based models of the blood-brain barrier (BBB) are important for increasing the knowledge of BBB formation, degradation and brain exposure of drug substances. Human models are preferred over animal models because of inter-species differences in B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3a6746d731f6132a7ff0f17af6c31311
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-16283
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-16283